Shopping Cart
Remove All
Your shopping cart is currently empty
GRA Ex-25 (GRA-Ex-25) is an inhibitor of glucagon receptor.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $48 | In Stock | In Stock | |
| 5 mg | $113 | In Stock | In Stock | |
| 10 mg | $173 | In Stock | In Stock | |
| 25 mg | $348 | In Stock | In Stock | |
| 50 mg | $523 | In Stock | In Stock | |
| 100 mg | $787 | In Stock | In Stock | |
| 200 mg | $1,070 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $139 | In Stock | In Stock |
| Description | GRA Ex-25 (GRA-Ex-25) is an inhibitor of glucagon receptor. |
| Targets&IC50 | Glucagon (human):55 nM, Glucagon (rat):56nM |
| In vitro | GRA Ex-25 binds to the human glucagon receptor (h-GlucRbind) with a Ki of 63 nM and exhibits moderate glucagon-induced adenylate cyclase inhibition (h-GlucRcyclase) with a Ki of 254 nM under our assay conditions[1], showing similar affinity for both rat and human glucagon receptors (IC50=56 and 55 nM, respectively)[2]. |
| In vivo | GRA Ex-25 (3 mg/kg, i.v.) significantly reduces blood glucose induced by exogenous glucagon in rat models, likely through direct inhibition of glucagon-stimulated hepatic glucose output[2]. |
| Synonyms | GRA-Ex-25 |
| Molecular Weight | 563.61 |
| Formula | C29H36F3N3O5 |
| Cas No. | 307983-31-9 |
| Smiles | CC(C)(C)[C@H]1CC[C@@H](CC1)N(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(OC(F)(F)F)cc1 |
| Relative Density. | 1.28 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (88.71 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.55 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.